Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.945 USD | +3.66% | +1.76% | +31.50% |
May. 07 | Bioventus Inc. Revises Earnings Guidance for the Full-Year 2024 | CI |
May. 07 | Transcript : Bioventus Inc., Q1 2024 Earnings Call, May 07, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+31.50% | 428M | |
+75.69% | 12.57B | |
+6.63% | 6.9B | |
+14.03% | 5.79B | |
-16.76% | 4.86B | |
+20.13% | 4.27B | |
-18.62% | 3.96B | |
-23.11% | 2.87B | |
+53.85% | 2.46B | |
+1.49% | 2.04B |
- Stock Market
- Equities
- BVS Stock
- News Bioventus Inc.
- Goldman Sachs Cuts Price Target on Bioventus to $2.50 From $13, Maintains Neutral Rating